EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extended ischemic times during ex vivo lung perfusion is not associated with increased mortality

Doug A Gouchoe iD, Divyaam Satija, Ervin Y Cui, Ahmed Aly, Matthew C Henn iD, Kukbin Choi, David Nunley, Nahush A Mokadam, Asvin M Ganapathi iD, Bryan A Whitson

Artificial Organs · 2024

DOI: 10.1111/aor.14820 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Artificial Organs, 2024. Verfasst von Doug A Gouchoe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Perfusion. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, HRSA HHS, Health Resources and Services Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The purpose of this study was to identify the association of increasing ischemic times in recipients who receive lungs evaluated by ex vivo lung perfusion (EVLP) and their association with outcomes following lung transplantation.

Methods

Lung transplant recipients who received an allograft evaluated by EVLP were identified from the United Network for Organ Sharing (UNOS) Database from 2016–2023. Recipients were stratified into three groups based on total ischemic time (TOT): short TOT (STOT, 0 to to 0.05 for both). On multivariable analysis, ischemic time was not associated with increased mortality whereas increasing recipient age, preoperative ECMO use and donation after circulatory death donors were ( p < 0.05 for all).

Conclusions

If EVLP technology is available, under certain circumstances, surgeons should not be dissuaded from using an allograft with extended ischemic time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung TransplantationPerfusionHumansFemaleMaleMiddle AgedAdultLungRetrospective StudiesOrgan PreservationTime FactorsLength of StayTissue DonorsHospital Mortality

Stichwörter der Autor:innen

ex vivo lung perfusionischemic timesoutcomestransplantation, lung

Autor:innen und Institutionen

  • Division of Cardiac Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • COPPER Laboratory, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
  • Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

ORCID-Profile: Doug A Gouchoe, Matthew C Henn, Asvin M Ganapathi

Förderung

  • NHLBI NIH HHS
  • HRSA HHS
  • Health Resources and Services Administration

Zitieren

APA

Gouchoe, D. A., Satija, D., Cui, E. Y., Aly, A., Henn, M. C., Choi, K., Nunley, D., Mokadam, N. A., Ganapathi, A. M., & Whitson, B. A. (2024). Extended ischemic times during ex vivo lung perfusion is not associated with increased mortality. Artificial Organs. https://doi.org/10.1111/aor.14820

Vancouver

Gouchoe DA, Satija D, Cui EY, Aly A, Henn MC, Choi K, et al. Extended ischemic times during ex vivo lung perfusion is not associated with increased mortality. Artificial Organs. 2024. doi:10.1111/aor.14820

BibTeX
@article{Gouchoe2024,
  author = {Gouchoe, Doug A and Satija, Divyaam and Cui, Ervin Y and Aly, Ahmed and Henn, Matthew C and Choi, Kukbin and Nunley, David and Mokadam, Nahush A and Ganapathi, Asvin M and Whitson, Bryan A},
  title = {Extended ischemic times during ex vivo lung perfusion is not associated with increased mortality},
  journal = {Artificial Organs},
  year = {2024},
  doi = {10.1111/aor.14820}
}
Kostenlos starten →